Lotus Mallbris

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Kenneth B. Gordon, Andrew Blauvelt, Kim Papp et al. · New England Journal of Medicine · 2016 · 838 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial

Robert Bissonnette, Kim Papp, Yves Poulin et al. · British Journal of Dermatology · 2016 · 418 citations · Full text

Life Sciences, Dermatology, Pharmacology +15

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

Lotus Mallbris, Olof Akre, Fredrik Granath et al. · European Journal of Epidemiology · 2004 · 392 citations

Medicine, Dermatology, Health Sciences +9

Psoriasis is associated with lipid abnormalities at the onset of skin disease

Lotus Mallbris, Fredrik Granath, Anders Hamsten et al. · Journal of the American Academy of Dermatology · 2006 · 354 citations

Medicine, Dermatology, Dermatopathology +12

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Eric L. Simpson, Robert Bissonnette, Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology · 2020 · 178 citations

Life Sciences, Dermatology, Immunology +11